Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Unani Formulations Picolin and Rasoline for PCOS
NCT06199544Phase 1Recruiting
- Sponsor
- Hamdard University
- Start
- Oct 2022
- Primary completion
- Jun 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Picolin and rosuvastatin in polycystic ovary syndrome (PCOS) (3 arms), sponsored by Hamdard University. Primary endpoint: Improvement in the menstrual regularity of the patient at 1 year. Started Oct 2022; status: recruiting.
02
Drugs
Picolinrosuvastatin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT06199544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06199544.